Trials / Completed
CompletedNCT03315793
A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
A Double-blind, Efficacy and Safety Study of Duloxetine Hydrochloride Versus Placebo in the Treatment of Japanese Children and Adolescents With Depressive Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 9 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy of duloxetine hydrochloride versus placebo in the treatment of Japanese children and adolescents with depressive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine Hydrochloride | Administered orally |
| DRUG | Placebo | Administered orally |
Timeline
- Start date
- 2017-12-04
- Primary completion
- 2019-11-08
- Completion
- 2019-11-08
- First posted
- 2017-10-20
- Last updated
- 2021-01-05
- Results posted
- 2021-01-05
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03315793. Inclusion in this directory is not an endorsement.